Ventyx Biosciences Statistics Share Statistics Ventyx Biosciences has 71.31M
shares outstanding. The number of shares has increased by 0.85%
in one year.
Shares Outstanding 71.31M Shares Change (YoY) 0.85% Shares Change (QoQ) 0.21% Owned by Institutions (%) 57.28% Shares Floating 63.19M Failed to Deliver (FTD) Shares 658 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 4.53M, so 6.36% of the outstanding
shares have been sold short.
Short Interest 4.53M Short % of Shares Out 6.36% Short % of Float 6.75% Short Ratio (days to cover) 10.35
Valuation Ratios The PE ratio is -1.11 and the forward
PE ratio is -1.84.
Ventyx Biosciences's PEG ratio is
0.03.
PE Ratio -1.11 Forward PE -1.84 PS Ratio 0 Forward PS 19.6 PB Ratio 0.59 P/FCF Ratio -1.14 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ventyx Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 17.97,
with a Debt / Equity ratio of 0.04.
Current Ratio 17.97 Quick Ratio 17.97 Debt / Equity 0.04 Debt / EBITDA -0.08 Debt / FCF -0.08 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.67M Employee Count 81 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 71.43% in the
last 52 weeks. The beta is 1.01, so Ventyx Biosciences's
price volatility has been higher than the market average.
Beta 1.01 52-Week Price Change 71.43% 50-Day Moving Average 2.69 200-Day Moving Average 2.04 Relative Strength Index (RSI) 74.33 Average Volume (20 Days) 966,961
Income Statement
Revenue n/a Gross Profit -1.35M Operating Income -148.45M Net Income -135.12M EBITDA -133.77M EBIT -135.12M Earnings Per Share (EPS) -1.97
Full Income Statement Balance Sheet The company has 27.26M in cash and 10.79M in
debt, giving a net cash position of 16.47M.
Cash & Cash Equivalents 27.26M Total Debt 10.79M Net Cash 16.47M Retained Earnings -554.31M Total Assets 230.01M Working Capital 207.85M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -130.87M
and capital expenditures -241K, giving a free cash flow of -131.11M.
Operating Cash Flow -130.87M Capital Expenditures -241K Free Cash Flow -131.11M FCF Per Share -1.91
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
